Trial Profile
Clinical Trials Insight: 700022613
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2010
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors YM BioSciences
- 20 Apr 2007 New trial record.